CHEMOTHERAPY OF ESOPHAGEAL CANCERS - EFFECT OF THE VINDESINE-CISPLATINUM-BLEOMYCIN ASSOCIATION

被引：0
|
作者：
BOURRY, J [1 ]
KHATER, R [1 ]
BOUBLIL, JL [1 ]
GIACOMINI, MA [1 ]
NAMER, M [1 ]
机构：
[1] CTR ANTOINE LACASSAGNE,F-06054 NICE,FRANCE
来源：
BULLETIN DU CANCER | 1985年 / 72卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [21] CHEMOTHERAPY FOR ESOPHAGEAL CANCER WITH MITOGUAZONE, METHOTREXATE, BLEOMYCIN, AND CISPLATIN
    VOGL, SE
    CAMACHO, F
    BERENZWEIG, M
    RUCKDESCHEL, J
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 21 - 23
  • [22] CHEMOTHERAPY OF CANCERS OF THE UPPER AERODIGESTIVE PATHWAYS (VADS) USING CISPLATINUM ALONE OR ASSOCIATED
    不详
    BULLETIN DU CANCER, 1985, 72 (04) : 330 - 330
  • [23] THE USE OF BELD COMBINATION CHEMOTHERAPY (BLEOMYCIN, VINDESINE, CCNU, AND DTIC) IN ADVANCED MALIGNANT-MELANOMA
    YOUNG, DW
    LEVER, RS
    ENGLISH, JSC
    MACKIE, RM
    CANCER, 1985, 55 (09) : 1879 - 1881
  • [24] 9 YEARS EXPERIENCE OF BELD COMBINATION CHEMOTHERAPY (BLEOMYCIN, VINDESINE, CCNU AND DTIC) FOR METASTATIC MELANOMA
    STABLES, GI
    DOHERTY, VR
    MACKIE, RM
    BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (05) : 505 - 508
  • [25] PHASE-II CHEMOTHERAPY TRIAL FOR BRONCHOPULMONARY CANCERS (EXCEPTING SMALL-CELL), USING CISPLATINUM-BLEOMYCIN-VINBLASTINE-FLUOROURACIL-METHOTREXATE-FOLINIC-ACID
    MARECHAL, F
    INCATASCIATO, C
    CATTAN, A
    BULLETIN DU CANCER, 1987, 74 (06) : 701 - 701
  • [26] Combinatory antitumor effect of chemotherapy and gene therapy for esophageal cancers using electroporation
    Matsubara, H
    Maeda, T
    Koide, Y
    Asano, T
    Ochiai, T
    Tagawa, M
    Sakiyama, S
    CANCER GENE THERAPY, 1998, 5 (06) : S25 - S25
  • [27] COMBINATION OF CHEMOTHERAPY WITH METHOTREXATE, BLEOMYCIN, AND CISPLATINUM, AND RADIATION-THERAPY FOR LOCALLY ADVANCED-CARCINOMA OF THE CERVIX
    GOLDHIRSCH, A
    GREINER, R
    BLEHER, A
    JESCHKO, M
    DREHER, E
    KRAUER, F
    CAVALLI, F
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 12 - 14
  • [28] RANDOMIZED CLINICAL-TRIAL OF PREOPERATIVE AND POSTOPERATIVE ADJUVANT CHEMOTHERAPY WITH CISPLATIN, VINDESINE, AND BLEOMYCIN FOR CARCINOMA OF THE ESOPHAGUS
    ROTH, JA
    PASS, HI
    FLANAGAN, MM
    GRAEBER, GM
    ROSENBERG, JC
    STEINBERG, S
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1988, 96 (02): : 242 - 248
  • [29] ASSOCIATION VINDESINE, CYCLOPHOSPHAMIDE, CISPLATIN AND CCNU IN ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    SPIELMANN, M
    KAC, J
    ELIAS, D
    CAILLE, P
    LECHEVALIER, T
    ROUGIER, P
    ZUMMER, K
    LASSER, P
    ROUESSE, J
    BULLETIN DU CANCER, 1985, 72 (03) : 220 - 226
  • [30] SUCCESSFUL COMBINATION CHEMOTHERAPY (CISPLATINUM, VINBLASTINE, AND BLEOMYCIN) AGAINST PERITONEAL DISSEMINATION OF INTRACRANIAL GERM-CELL TUMOR
    KUMURA, E
    ARITA, N
    HAYAKAWA, T
    USHIO, Y
    NAKATA, H
    MURASAWA, A
    MOGAMI, H
    IKEZOE, J
    MINAMI, Y
    NEUROSURGERY, 1986, 18 (06) : 802 - 804
12345